14-day Premium Trial Subscription Try For FreeTry Free
$9.06
+0.0500 (+0.555%)
At Close: Apr 23, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 08, 2024 Sell 3 435 Henderson Molly Common Stoock
Mar 22, 2024 Sell 16 851 Curran Terrie Common Stock
Jan 24, 2024 Buy 0 Medicxi Ventures Management (jersey) Ltd Common Stock
Jan 24, 2024 Buy 0 Medicxi Ventures Management (jersey) Ltd Common Stock
Jan 24, 2024 Buy 0 Medicxi Ventures Management (jersey) Ltd Common Stock
Jan 24, 2024 Buy 0 Medicxi Ventures Management (jersey) Ltd Common Stock
Jan 24, 2024 Sell 3 703 703 Takeda Pharmaceutical Co Ltd Common Stock
Jan 19, 2024 Sell 6 307 Henderson Molly Common Stock
Jan 18, 2024 Buy 120 000 Henderson Molly Stock Option (Right to Buy)
Jan 18, 2024 Buy 130 000 Nabulsi Azmi Stock Option (Right to Buy)
Jan 18, 2024 Buy 475 000 Curran Terrie Stock Option (Right to Buy)
Nov 20, 2023 Sell 2 127 Henderson Molly Common Stock
Nov 08, 2023 Buy 2 500 Parikh Asit Common Stock
Nov 07, 2023 Buy 4 000 Parikh Asit Common Stock
Nov 06, 2023 Buy 1 000 Parikh Asit Common Stock
Nov 01, 2023 Buy 22 500 Henderson Molly Common Stock
Nov 01, 2023 Sell 811 Henderson Molly Common Stock
Nov 01, 2023 Sell 11 681 Henderson Molly Common Stock
Nov 01, 2023 Buy 32 500 Nabulsi Azmi Common Stock
Nov 01, 2023 Buy 37 500 Curran Terrie Common Stock
Jul 14, 2023 Buy 25 000 Henderson Molly Common Stock
Jul 14, 2023 Buy 25 000 Henderson Molly Common Stock
Jul 14, 2023 Buy 200 000 Curran Terrie Common Stock
Jul 14, 2023 Sell 175 000 Curran Terrie Stock Option
Jul 14, 2023 Sell 225 000 Curran Terrie Stock Option
Jul 14, 2023 Buy 110 000 Nabulsi Azmi Common Stock
Jul 14, 2023 Sell 70 000 Nabulsi Azmi Stock Option
Jul 14, 2023 Sell 150 000 Nabulsi Azmi Stock Option
Jun 02, 2023 Buy 15 000 Parikh Asit Common Stock
Jun 02, 2023 Sell 15 000 Parikh Asit Stock Option (Right to Buy)
Jun 02, 2023 Sell 1 960 Henderson Molly Common Stock
May 25, 2023 Buy 9 000 Topper James N Common Stock
May 25, 2023 Buy 15 000 Topper James N Stock Option (Right to Buy)
May 25, 2023 Buy 15 000 Stenhouse Mark Stock Option (Right to Buy)
May 25, 2023 Buy 9 000 Stenhouse Mark Common Stock
May 25, 2023 Buy 15 000 Socks David A Stock Option (Right to Buy)
May 25, 2023 Buy 9 000 Socks David A Common Stock
May 25, 2023 Buy 9 000 Parikh Asit Common Stock
May 25, 2023 Buy 15 000 Parikh Asit Stock Option (Right to Buy)
May 25, 2023 Buy 15 000 Fields Heidi Stock Option (Right to Buy)
May 25, 2023 Buy 9 000 Fields Heidi Common Stock
May 25, 2023 Buy 15 000 Karbe Frank Stock Option (Right to Buy)
May 25, 2023 Buy 9 000 Karbe Frank Common Stock
May 25, 2023 Buy 9 000 Cola Michael F Common Stock
May 25, 2023 Buy 15 000 Cola Michael F Stock Option (Right to Buy)
May 22, 2023 Sell 2 110 Henderson Molly Common Stock
Apr 11, 2023 Buy 10 000 Nabulsi Azmi Common Stock
Apr 10, 2023 Buy 1 000 Parikh Asit Common Stock
Apr 06, 2023 Buy 12 919 Curran Terrie Common Stock
Apr 06, 2023 Sell 3 439 Henderson Molly Common Stock
Mar 01, 2023 Sell 2 032 Henderson Molly Common Stock
Mar 01, 2023 Sell 1 436 Curran Terrie Common Stock
Feb 13, 2023 Buy 5 000 Parikh Asit Common Stock
Jan 20, 2023 Sell 5 821 Curran Terrie Common Stock
Jan 19, 2023 Buy 97 500 Curran Terrie Common Stock
Jan 19, 2023 Buy 162 500 Curran Terrie Stock Option (Right to Buy)
Jan 19, 2023 Buy 45 000 Nabulsi Azmi Common Stock
Jan 19, 2023 Buy 75 000 Nabulsi Azmi Stock Option (Right to Buy)
Jan 19, 2023 Buy 33 000 Henderson Molly Common Stock
Jan 19, 2023 Buy 55 000 Henderson Molly Stock Option (Right to Buy)
Jan 12, 2023 Buy 5 000 Parikh Asit Common Stock
Nov 21, 2022 Sell 2 159 Henderson Molly Common Stock
Nov 21, 2022 Sell 1 526 Curran Terrie Common Stock
Sep 22, 2022 Buy 20 000 Topper James N Stock Option (Right to Buy
Sep 01, 2022 Buy 7 500 Curran Terrie Common Stock
Sep 01, 2022 Buy 7 500 Nabulsi Azmi Common Stock
Sep 01, 2022 Buy 7 500 Henderson Molly Common Stock
May 25, 2022 Buy 15 000 Stenhouse Mark Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Stenhouse Mark Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Socks David A Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Parikh Asit Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Fields Heidi Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Fields Heidi Stock Option (Right to Buy)
May 25, 2022 Buy 10 000 Karbe Frank Stock Option (Right to Buy)
May 25, 2022 Buy 10 000 Karbe Frank Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Cola Michael F Stock Option (Right to Buy)
May 25, 2022 Buy 15 000 Cola Michael F Stock Option (Right to Buy)
May 19, 2022 Buy 12 000 Nabulsi Azmi Common Stock
May 19, 2022 Buy 12 000 Henderson Molly Common Stock
May 19, 2022 Buy 12 000 Curran Terrie Common Stock
May 16, 2022 Buy 20 000 Nabulsi Azmi Common Stock
May 13, 2022 Buy 20 500 Curran Terrie Common Stock
May 13, 2022 Buy 6 000 Henderson Molly Common Stock
May 13, 2022 Buy 6 000 Henderson Molly Common Stock
May 12, 2022 Buy 12 500 Parikh Asit Common Stock
Apr 25, 2022 Buy 20 000 Karbe Frank Stock Option (Right to Buy)
Apr 25, 2022 Buy 20 000 Karbe Frank Stock Option (Right to Buy)
Apr 25, 2022 Buy 0 Karbe Frank
Apr 05, 2022 Buy 100 000 Henderson Molly Stock Option (Right to Buy)
Apr 05, 2022 Buy 100 000 Henderson Molly Stock Option (Right to Buy)
Apr 05, 2022 Buy 20 000 Henderson Molly Common Stock
Apr 05, 2022 Buy 0 Henderson Molly
Mar 14, 2022 Buy 7 359 304 Takeda Pharmaceutical Co Ltd Common Stock
Mar 14, 2022 Sell 18 Takeda Pharmaceutical Co Ltd Common Stock
Mar 14, 2022 Sell 7 359 304 Takeda Pharmaceutical Co Ltd Warrants
Jan 19, 2022 Buy 0 Curran Terrie
Jan 19, 2022 Buy 97 500 Nabulsi Azmi Stock Option (Right to Buy)
Jan 19, 2022 Buy 19 500 Nabulsi Azmi Common Stock
Jan 19, 2022 Buy 30 000 Guzzo Anthony J. Stock Option (Right to Buy)
Oct 29, 2019 Buy 9 798 Cola Michael F Common Stock
JSON CSV
INSIDER POWER
-48.257
Last 100 transactions
Buy: 9 929 521 | Sell: 11 759 720 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -48.257.

In total, the insiders bought 9 929 521 and sold 11 759 720 PHAT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT